Tuesday, September 19, 2017 8:39:10 PM
See pallitech is a private company and wants cash not preferred shares or common stock from evio.
I see this as potentially a very well crafted shares based merger where note holders act as a middleman.
Now this could happen more often but I think once WW gets the pps and financials in a better position we could see real equity financing, but this is pretty damn crafty IMHO if I'm correct.
We will see more dilution for sure but no one complained last yr when dilution financed 5 labs and what is now the backbone of Evio today.
Will said on an OTC market podcast otcQX is next and NASDAQ in 18 months or so. They need more by way of assets to get there.
Until QX I don't see a chance in hell of attractive equity financing... Maybe not even until NASDAQ given this is a shifty area of business in the MJ industry
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM